Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)

Market Cap	4.74B
Revenue (ttm)	2.13B
Net Income (ttm)	259.93M
Shares Out	400.38M
EPS (ttm)	0.63
PE Ratio	18.85
Forward PE	10.57
Dividend	0.20 (1.69%)
Ex-Dividend Date	n/a

Volume	2,884,300
Average Volume	4,706,344
Open	11.88
Previous Close	11.88
Day's Range	11.84 - 11.96
52-Week Range	10.69 - 16.79
Beta	0.82
RSI	36.67
Earnings Date	Apr 23, 2025

About SHA:603439

GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. It offers pediatric medication, respiratory system medication, cardiovascular drugs, injury by fall medication, rehabilitation medicine, GI medicine, and ophthalmic medicine. The company was founded in 1995 and is based in Anshun, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 2,282
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603439

Financial Performance

In 2024, SHA:603439's revenue was 2.14 billion, an increase of 31.16% compared to the previous year's 1.63 billion. Earnings were 274.03 million, a decrease of -6.38%.